Pair of ex-HHS coun­sels crit­i­cize bill to 'u­pend' 180-day ex­clu­siv­i­ty for first gener­ic drugs

Three years ago, a pair of bi­par­ti­san con­gress­men in­tro­duced leg­is­la­tion called the “Bring­ing Low-cost Op­tions and Com­pe­ti­tion while Keep­ing In­cen­tives for New Gener­ics,” or BLOCK­ING …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER